Sex steroid hormone influences replication of major HIV subtypes

Size: px
Start display at page:

Download "Sex steroid hormone influences replication of major HIV subtypes"

Transcription

1 Sex steroid hormone influences replication of major HIV subtypes Viswanath Ragupathy, Ph.D CBER/FDA Bethesda, MD st International Workshop on HIV & Women from Adolescence through Menopause Washington DC, Jan -,, 20

2 Background According to UNAIDS, almost half of all HIV- infected individuals worldwide are women. Studies comparing the course of HIV- infection between women and men have demonstrated considerable sex differences in the manifestations of HIV- disease (Nat.Med 2009). HIV- infected women tend to have lower viral loads early in HIV- infection but progress faster to AIDS for a given viral load than men (Gandhi et al 2002). Is HIV progression sex-linked? A genetic variant on the X chromosome may explain why some HIV-infected women are slower to develop full-blown AIDS than men. Single nucleotide polymorphism (SNP) of 6-7% located on the X chromosome significantly reduced rate of CD4 cell loss throughout the disease's progression and a lower viral load (The scientist 3 th Aug 2009) Women appear to be more susceptible to HIV- infection, but have lower plasma viral RNA levels and a more diverse population of HIV- variants.

3 Cont.. It has also been reported that there may be subtype specific differences in rates of disease progression (Laeyendecker, O. et al. CROI meeting abstracts, 2006) beta-estradiol attenuates HIV- replication in both primary human PBL and antiretroviral efficacy of D4T in PBL cultures (Zhang M et al 2008). Esterdiol and Progesterone regulate HIV - replication in peripheral blood cells at mid-proliferative phase (low hormone) increased replication, and midsecretary phase (high hormone) decreased HIV- replication (Asin et al 2008). Hormonal contraception verses HIV acquisition studies resulted in conflict results (Hormonal Contraception & HIV An Update 2004) Thus wish explore the pathogenesis of different HIV variants in the cells from male and female donors in the presence or absence of sex steroid hormones.

4 Objectives To study the replication capacity of HIV clades sex specific variations in replication of clades effect of sex hormones on replication of clades HIV replication kinetics within and between males and females in PBMC, Dc & macrophages

5 Methods Fresh/Frozen donor PBMC of 6 Female & 6 males were cultured with RPMI (5%FBS & IL2 media and seeded at a concentration of million cells/ml in a 24 well plate. For Dendritic Cells (DC) and Macrophages fresh monocytes were obtained from buffy coat of either gender and cultured, differentiated with RPMI (5%FBS) media containing IL4/MCSF. HIV subtype ASI, BNSI, CNSI, DSI, FSI, CRF0, CRF02, MN strain and HIV-2, Group O & N ( strains) were infected at a concentration of ng p24 per million cells. After 2 hours of incubation at 37c, 5%co2, cells were washed and cultured for 4 days. Dc s s co-cultured cultured with autologus PBMC. HIV replication was measured with quantization of p24/p27 (Perkin Elmer/Zeptometric kits) values in culture sups at,7 and 4.

6 Methods Cont Female hormone concentrations used: Esterdiol Progesterone Testosterone : nm/ml and.75 micro molar/ml : 2.5nM/ml and 64nm/ml : 3.5nM/ml Male hormone concentrations used: Esterdiol Progesterone Testosterone : 40pM/ml and 40pM/ml : pm/ml : 2ng/ml and ng

7 Results Invitro HIV Clade dynamics PBMC Least square Least Sq means Mean high moderate low Sub B Sub C CRF0 GR-N Sub D Sub A MN

8 Results cont. PBMC Subtype F, CRF02, Group O did not establish good infection. Among the viruses kinetics studied Sub B > Sub C > CRF0, Sub A & D > MN in both the genders. However the rates were varied between the gender.

9 Results cont.. HIV clade dynamics between gender Least Sq Mean Female Females cells ~60% more susceptible to infection Male

10 Progesterone down regulates HIV MN Strain (clade B) in cells from Women but not in Men Strain MN (W2) Day 2 0. No Hor Low.Est High Est Low Prog High Prog Test Strain MN (M) Strain MN (W) Day 2 Day 2 No Hor Low.Est High Est Low Prog High Prog Test No Hor Low.Est High Est Prog Low Test High Test

11 Progesterone/estrogen has opposite effects with HIV CRF0_AE in cells from Women and Men 0 CRF0_AE (W2) Day 2 0. No Hor Low.Est High Est Low Prog High Prog Test 00 CRF0_AE (M) Day 2 0 No Hor Low.Est High Est Prog Low Test High Test

12 HIV clades differentially regulated by hormones in cells from Women and Men 00 0 Clade A (W2) Day 2 0 CRF0_AE (W) Day 2 No Hor Low.Est High Est Low Prog High Prog Test 0. No Hor Low.Est High Est Low Prog High Prog Test 0 Clade C (M) Day Clade C (M2) Day 2 No Hor Low.Est High Est Prog Low Test High Test No Hor Low.Est High Est Prog Low Test High Test

13 Sex Hormones suppress/stimulate HIV replication in certain donors 00 Clade B (M3) Day 2 0 No Hor Low.Est High Est Prog Low Test High Test 00 0 Clade B (W) Day 2 0 Clade C (W2) Day 2 No Hor Low.Est High Est Low Prog High Prog Test No Hor Low.Est High Est Low Prog High Prog Test

14 Jurkat/H9 cells To study HIV clades infectivity with & w/o hormone MN (HIV MN strain) Strain Day Low High 0 No Hormone Low Estrogen High Estrogen Low Progesterone High Progesterone Low Testosterone High Testosterone

15 Previous studies had reported that the R5/X4 determines the infectivity, we wish to determine R5/X4 expression levels with and w/o hormone.

16 Effect of Hormones on CD4-CCR5/CxCR4 PBMC Counts CD4 CxCR4 CCR No Hormone Estrogen Progesterone Testosterone Mix CD4/X4/R5 Change No change in X4/R5 Change

17 Effect of Hormones on CD4-CCR5/CxCR4 T-cell lines

18 Effect of Hormones on CD4/CCR5/CxCR %Max CD4 CCR5 CXCR No Hor Est Prog Test Est/Prog

19 Conclusions Part PBMC cells from female donor cells showed higher susceptibility to infection than male cells. Sex hormones affect HIV replication kinetics and possibly at the receptor level (CD4, R5 or X4) Cell lines were less sensitive for infectivity of HIV clades at p24 concentrations used for primary cells.

20 Monocyte derived dendritic (MDDC) cells in transmission of HIV subtypes between the gender

21 Background Majority of HIV transmissions world wide is through sexual route(70 (70-80%). The probability of sexual HIV- transmission from female-to male (0 04%( 04% per act [95% CI ]) 4]) and male-to to-female (0 08%( 08% per act [95% CI ]) in high income countries, Low-income countries female-to to-male (0 38% per act [95% CI ]) ]) and male-to to-female (0 30%( per act [95% CI ]) (Lancet( Infect Dis 2009) DCs are thought to be involved in the sexual transmission of HIV-. In humans, two main DC subsets have been identified: CDc+ myeloid DC (MDC) and CDc- CD23+ plasmacytoid DC (PDC). Several in vivo studies indicate that intraepithelial and submucosal MDC are the first cell types that are the target of HIV/SIV after intravaginal infection. Thus, MDC play a crucial role in sexual HIV- transmission through viral capture in the mucosa and subsequent transfer to T cells. Hence we wish to study HIV clades transmission kinetics with and w/o sex hormones.

22 Adsorption and Transmission events through MDDC HIV Capture Trafficking Transmission Persistent infection

23 Results DC 2hrs post infection M W HIV-I/II, p24/p27 pg/ml HIV-2 CRF02_AG Clade C Clade B Group O Uninfected

24 HIV replication kinetics in DC, w/o PBMC co culture HIV-/2 p24/p27 pg/ml W CRF02 Sub C Sub B HIV-2 HIV-/2 p24/p27 pg/ml W2 CRF02 Sub C Sub B HIV-2 GR-O M M2 HIV-/2 p24/p27 pg/ml 0. CRF02 Sub C Sub B HIV-2 GR-O HIV-/2 p24/p27 pg/ml CRF02 Sub C Sub B HIV-2 GR-O

25 Donor to Donor variations of HIV infection in DC HIV kinetics in DC 7 days post infection Donors HIV-I/II, p24/p27 pg/ml W W2 W3 W4 W5 Dc s from Women - CRF02_AG Clade C Clade B HIV-2 Group O HIV kinetics in DC 7 days post infection Donors 5 M Dc s from Men HIV-I/II, p24/p27 pg/ml M2 M3 M4 M5 - CRF02_AG Clade C Clade B HIV-2 Group O ~ -3 log differences in infectivity

26 HIV-I p24 pg/ml 0 Clade B W Estrogen down regulates certain clades in DC to autologus t-cell transmission 0 Clade C M2 No Hor Low Est High Est Low Prog High Prog Test Group O W No Hor Low.Est High Est Low Test High Test Prog HIV-2 W5 HIV-I p24 pg/ml No Hor Low Est High Est Low Prog High Prog Test Clade C W 0. 0 No Hor Low.Est High Est Low Prog High Prog Test Clade B W2 HIV-I p24 pg/ml 0 0. No Hor Low Est High Est Low Prog High Prog Test No Hor Low.Est High Est Low Prog High Prog Test

27 Progesterone down regulates certain clades in DC to autologus t-cell transmission HIV-2 M HIV-2 p27 pg/ml No Hor Low.Est High Est Low Test High Test Prog Clade C W4 No Hor Low.Est High Est Low Prog High Prog Test

28 Testosterone down regulates certain clades in DC to autologus t-cell transmission 0 Clade C M3 Clade B M2 No Hor Low.Est High Est Low Test High Test Prog No Hor Low.Est High Est Low Test High Test Prog HIV-2 M2 0 Clade C M HIV-2 p27 pg/ml 0. No Hor Low.Est High Est Low Test High Test Prog No Hor Low.Est High Est Low Test High Test Prog

29 In some donors two hormones down regulates certain clades in DC to autologus t-cell transmission HIV-2 W4 0. No Hor Low.Est High Est Low Prog High Prog Test Clade B W5 No Hor Low.Est High Est Low Prog High Prog Test

30 In certain donors hormones do not impact in DC to autologus t-cell transmission 0 Clade C W5 No Hor Low.Est High Est Low Prog High Prog Test

31 Hormones modulate HIV replication in Monocyte derived Macrophages (MDMs) of either gender 20 yr old male Clade B yr old female Clade B Day 3 Day Day 3 Day 6 Day Day p24 pg/ml 800 p24mpg/ml Estrogen.75 mm Estrogen nm Estrogen 40 pm Estrogen 40 pm Progesterone 64 nm Progesterone 32 nm Progesterone 2.5 nm Progesterone pm Testosterone ng/ml Testosterone 5 ng/ml Testosterone 2 ng/ml Testosterone ng/ml Control Estrogen.75 mm Estrogen nm Estrogen 40 pm Estrogen 40 pm Progesterone 64 nm Progesterone 32 nm Progesterone 2.5 nm Progesterone pm Testosterone ng/ml Testosterone 5 ng/ml Testosterone 2 ng/ml Testosterone ng/ml Control 4 yr old female clade C yr male Clade C Day 3 Day 6 Day Day 3 Day 6 Day Estrogen 75 nm Estrogen nm Estrogen 40 pm Estrogen 40 pm Progesterone 64 nm Progesterone 32 nm Progesterone 2.5 nm Progesterone pm Testosterone ng/ml Testosterone 5 ng/ml Testosterone 2 ng/ml Testosterone ng/ml Control Estrogen 75 nm Estrogen nm Estrogen 40 pm Estrogen 40 pm Progesterone 64 nm Progesterone 32 nm Progesterone 2.5 nm Progesterone pm Testosterone ng/ml Testosterone 5 ng/ml Testosterone 2 ng/ml Testosterone ng/ml 0 0 Control

32 Conclusions part 2 Significant donor to donor variation was observed. Similar to PBMC clades B and C transmit efficiently compared with other clades HIV-2 2 and Group O did not show productive infection in certain donor cells Estrogen/Progesterone modulation of HIV- replication in MDMs was more consistent in female than male donors. Hormone treatment had impact on transmission kinetics but was not consistent among various clades and donors Further studies are needed to evaluate these observations and their in vivo significance.

33 Acknowledgements Lab of Molecular Virology/CBER Indira Hewlett, Ph.D Krishna Devadas, Ph.D Owen Wood, Ph.D Sherwin Lee, BS Andy Dayton, M.D., Ph.D Office of Biostatistics and Epidemiology Funding Ghanshyam Gupta FDA s Office of Women s Health Jiangqin Zhao, M.D., Ph.D Shixing Tang, M.D., Ph.D Armeta D, BS

Modulation of HIV replication by steroid hormones in monocyte derived macrophages

Modulation of HIV replication by steroid hormones in monocyte derived macrophages Modulation of HIV replication by steroid hormones in monocyte derived macrophages Krishnakumar Devadas, Ph.D. Laboratory of Molecular Virology Division of Emerging and Transfusion Transmitted Diseases

More information

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per

More information

CBER update and International Collaboration for development of HIV variant panels

CBER update and International Collaboration for development of HIV variant panels CBER update and International Collaboration for development of HIV variant panels Indira K. Hewlett, Ph.D Chief, Laboratory of Molecular Virology DETTD/CBER/FDA XXII SoGAT meeting HIV genetic diversity:

More information

MID 36. Cell. HIV Life Cycle. HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Entry. Life Cycle of HIV HIV Entry. Scott M. Hammer, M.D.

MID 36. Cell. HIV Life Cycle. HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Entry. Life Cycle of HIV HIV Entry. Scott M. Hammer, M.D. Life Cycle Diagnosis and Pathogenesis Scott M. Hammer, M.D. -1 Virion Entry Life Cycle of Entry -1 virion -1 Virus virion envelope Cell membrane receptor RELEASE OF PROGENY VIRUS REVERSE Co- TRANSCRIPTION

More information

Hormonal Contraception and the Risk of HIV Acquisition

Hormonal Contraception and the Risk of HIV Acquisition Hormonal Contraception and the Risk of HIV Acquisition Charles Morrison, PhD International Conference on Family Planning Kampala, Uganda November 16, 2009 Hormonal Contraception and HIV About 16 million

More information

Fertility Desires/Management of Serodiscordant HIV + Couples

Fertility Desires/Management of Serodiscordant HIV + Couples Fertility Desires/Management of Serodiscordant HIV + Couples William R. Short, MD, MPH Assistant Professor of Medicine Division Of Infectious Diseases Jefferson Medical College of Thomas Jefferson University

More information

HIV/AIDS & Immune Evasion Strategies. The Year First Encounter: Dr. Michael Gottleib. Micro 320: Infectious Disease & Defense

HIV/AIDS & Immune Evasion Strategies. The Year First Encounter: Dr. Michael Gottleib. Micro 320: Infectious Disease & Defense Micro 320: Infectious Disease & Defense HIV/AIDS & Immune Evasion Strategies Wilmore Webley Dept. of Microbiology The Year 1981 Reported by MS Gottlieb, MD, HM Schanker, MD, PT Fan, MD, A Saxon, MD, JD

More information

Hormonal Contraception and HIV

Hormonal Contraception and HIV Hormonal Contraception and HIV A ROUNDTABLE AT THE INTEREST WORKSHOP, LUSAKA, 2014 Professor Helen Rees, Wits RHI, Johannesburg, SA Dr Mike Mbizvo, Zimbabwe Dr Chelsea Polis, USAID, Washington Dr Nelly

More information

Immunodeficiency. (2 of 2)

Immunodeficiency. (2 of 2) Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related

More information

CROI 2017 Highlights What s New in Antiretrovirals (Part 2)

CROI 2017 Highlights What s New in Antiretrovirals (Part 2) Mountain West AIDS Education and Training Center CROI 2017 Highlights What s New in Antiretrovirals (Part 2) Ann Collier, MD This presentation is intended for educational use only, and does not in any

More information

HIV Prevention in Clinical Care Settings

HIV Prevention in Clinical Care Settings NORTHWEST AIDS EDUCATION AND TRAINING CENTER HIV Prevention in Clinical Care Settings Jeanne Marrazzo, MD, MPH Professor, Division of Allergy and Infectious Diseases University of Washington HIV Prevention

More information

Understanding contraceptive choices among a cohort of HIV-positive women

Understanding contraceptive choices among a cohort of HIV-positive women Understanding contraceptive choices among a cohort of HIV-positive women Malika Sharma, MD FRCPC with Blitz S, Walmsley S, Raboud J, Money D for the CTN 236 investigators January 13, 2014 Conflict of Interest

More information

Whole genome deep sequencing of HIV reveals extensive multi-class drug resistance in Nigerian patients failing first-line antiretroviral therapy

Whole genome deep sequencing of HIV reveals extensive multi-class drug resistance in Nigerian patients failing first-line antiretroviral therapy Whole genome deep sequencing of HIV reveals extensive multi-class drug resistance in Nigerian patients failing first-line antiretroviral therapy K El Bouzidi 1,, RP Datir 1, V Kwaghe 3, S Roy 1, D Frampton

More information

Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells

Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells Sharon A. Riddler, MD, MPH University of Pittsburgh May 2008 Slide 1 HIV and DC Vaccines During

More information

What makes the transmitted HIV-1 in newly infected patients unique from the donor inoculum?

What makes the transmitted HIV-1 in newly infected patients unique from the donor inoculum? What makes the transmitted HIV-1 in newly infected patients unique from the donor inoculum? What happens during primary infection? Los Alamos National Laboratories Evidence of the genetic bottleneck at

More information

Human Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4

Human Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4 Human Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4 Ankita Garg, Rodney Trout and Stephen A. Spector,,* Department

More information

A Summary of Clinical Evidence

A Summary of Clinical Evidence A Summary of Clinical Evidence Supporting the use of the Alere Determine HIV-1/2 Ag/Ab Combo Rapid Test to assist in the diagnosis of Human Immunodeficiency Virus (HIV) TAP HERE TO SEE THE PRODUCTS Table

More information

PRO140 SC Monotherapy (MT) Provides Long-Term, Full Virologic Suppression in HIV Patients

PRO140 SC Monotherapy (MT) Provides Long-Term, Full Virologic Suppression in HIV Patients PRO140 SC Monotherapy (MT) Provides Long-Term, Full Virologic Suppression in HIV Patients Jay Lalezari, Kush Dhody, Ula Kowalczyk, Kazem Kazempour, Nader Pourhassan, and Paul J. Maddon 1 ASM Microbe 2016

More information

Rationale for therapy at PHI

Rationale for therapy at PHI Rationale for therapy at PHI Immunological: Interfere with pathogenesis Preserve HIV-specific CD4+ T-help Reduce T-cell activation Virological: Prevent or reduce seeding of reservoirs Affect viral set

More information

CDC site UNAIDS Aids Knowledge Base http://www.cdc.gov/hiv/dhap.htm http://hivinsite.ucsf.edu/insite.jsp?page=kb National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov/default.htm

More information

Pharmacokinetic and pharmacodynamic profile of maraviroc in rhesus macaques after a single oral dose

Pharmacokinetic and pharmacodynamic profile of maraviroc in rhesus macaques after a single oral dose HIV Transmission Workshop 011 Pharmacokinetic and pharmacodynamic profile of maraviroc in rhesus macaques after a single oral dose Wutyi Aung, Amy Martin, Mian-er Cong, Jessica Radzio, Elizabeth Sweeney,

More information

BIOLOGICAL/IMMUNOLOGICAL CONSIDERATIONS MOVING TOWARD A 3-MONTH CONTRACEPTIVE DAPIVIRINE RING

BIOLOGICAL/IMMUNOLOGICAL CONSIDERATIONS MOVING TOWARD A 3-MONTH CONTRACEPTIVE DAPIVIRINE RING BIOLOGICAL/IMMUNOLOGICAL CONSIDERATIONS MOVING TOWARD A 3-MONTH CONTRACEPTIVE DAPIVIRINE RING Sharon Achilles, MD, PhD MTN Annual Meeting March 15, 2016 Nothing to disclose. Research funding: NIH/NIAID

More information

Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence

Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine Viral suppression

More information

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS Human Immunodeficiency Virus Acquired Immune Deficiency Syndrome AIDS Sudden outbreak in USA of opportunistic infections and cancers in young men in 1981 Pneumocystis carinii pneumonia (PCP), Kaposi s

More information

DC-SIGN on B Lymphocytes Is Required For Transmission of HIV-1 to T Lymphocytes

DC-SIGN on B Lymphocytes Is Required For Transmission of HIV-1 to T Lymphocytes DC-SIGN on B Lymphocytes Is Required For Transmission of HIV-1 to T Lymphocytes Giovanna Rappocciolo 1*, Paolo Piazza 1, Craig L. Fuller 1, Todd A. Reinhart 1, Simon C. Watkins 2, David T. Rowe 1, Mariel

More information

Reverse transcriptase and protease inhibitor resistant mutations in art treatment naïve and treated hiv-1 infected children in India A Short Review

Reverse transcriptase and protease inhibitor resistant mutations in art treatment naïve and treated hiv-1 infected children in India A Short Review pissn 2349-2910 eissn 2395-0684 REVIEW Reverse transcriptase and protease inhibitor resistant mutations in art treatment naïve and treated hiv-1 infected children in India A Short Review Dinesh Bure, Department

More information

HIV Testing. Susan Tusher, LMSW Program Coordinator The Kansas AIDS Education and Training Center

HIV Testing. Susan Tusher, LMSW Program Coordinator The Kansas AIDS Education and Training Center HIV Testing Susan Tusher, LMSW Program Coordinator The Kansas AIDS Education and Training Center The Number of Persons in the US Living with HIV Continues to Increase Over 1 Million people are estimated

More information

Advances in HIV science and treatment. Report on the global AIDS epidemic,

Advances in HIV science and treatment. Report on the global AIDS epidemic, HIV biomolecular advances and treatment updates David A Cooper National Centre in HIV Epidemiology and Clinical Research The University of New South Wales Sydney, Australia UNAIDS: global l HIV infections

More information

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group) AIDS Vaccine 07, Seattle, August 20-23, 2007 EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV (Summary of the recommendations from an Enterprise Working Group) The Working Group Reston, Virginia,

More information

Antibody Dependent Cellular Cytotxic activity: Past and Future. Guido Ferrari, M.D. Duke University Medical Center

Antibody Dependent Cellular Cytotxic activity: Past and Future. Guido Ferrari, M.D. Duke University Medical Center Antibody Dependent Cellular Cytotxic activity: Past and Future Guido Ferrari, M.D. Duke University Medical Center Mechanism of Antibody Dependent Cellular Cytotoxicity (ADCC) ADCC Effector Cells (NK, monocytes/macrophages,

More information

pplementary Figur Supplementary Figure 1. a.

pplementary Figur Supplementary Figure 1. a. pplementary Figur Supplementary Figure 1. a. Quantification by RT-qPCR of YFV-17D and YFV-17D pol- (+) RNA in the supernatant of cultured Huh7.5 cells following viral RNA electroporation of respective

More information

Decay characteristics of HIV-1- infected compartments during combination therapy

Decay characteristics of HIV-1- infected compartments during combination therapy Decay characteristics of HIV-1- infected compartments during combination therapy Perelson et al. 1997 Kelsey Collins BIOL0380 September 28, 2009 SUMMARY Analyzed decay patterns of viral load of HIV- 1-infected

More information

Situation of XMRV and Blood Transfusion. Celso Bianco, MD ISBT Working Party on TTID Lisbon, June 19, 2011

Situation of XMRV and Blood Transfusion. Celso Bianco, MD ISBT Working Party on TTID Lisbon, June 19, 2011 Situation of XMRV and Blood Transfusion Celso Bianco, MD ISBT Working Party on TTID Lisbon, June 19, 2011 Lombardi et al. Science 326, 585 (2009) Conclusions: CFS and XMRV XMRV found in 67% of CFS patients

More information

High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity

High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1635 1641 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.01478-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. High Failure

More information

HIV replication and selection of resistance: basic principles

HIV replication and selection of resistance: basic principles HIV replication and selection of resistance: basic principles 26th International HIV Drug Resistance and Treatment Strategies Workshop Douglas Richman 6 November 2017 CLINICAL DATA DURING SIXTEEN WEEKS

More information

Identifying Biologic Targets to Attenuate or Eliminate Asthma Exacerbations

Identifying Biologic Targets to Attenuate or Eliminate Asthma Exacerbations Identifying Biologic Targets to Attenuate or Eliminate Exacerbations exacerbations are a major cause of disease morbidity and costs. For both children and adults, viral respiratory infections are the major

More information

HIV Basics: Pathogenesis

HIV Basics: Pathogenesis HIV Basics: Pathogenesis Michael Saag, MD, FIDSA University of Alabama, Birmingham Director, Center for AIDS Research ACTHIV 2011: A State-of-the-Science Conference for Frontline Health Professionals Learning

More information

MID-TERM EXAMINATION

MID-TERM EXAMINATION Epidemiology 227 May 2, 2007 MID-TERM EXAMINATION Select the best answer for the multiple choice questions. There are 75 questions and 11 pages on the examination. Each question will count one point. Notify

More information

WVU Occupational Medicine Program for evaluation and treatment of persons exposed to Lentivirus Vectors

WVU Occupational Medicine Program for evaluation and treatment of persons exposed to Lentivirus Vectors Hazard Description: Lentivirus vector systems are derived from HIV and similar viruses because of being very effective at inserting genetic material into the genome of target cells. While most researchers

More information

colorimetric sandwich ELISA kit datasheet

colorimetric sandwich ELISA kit datasheet colorimetric sandwich ELISA kit datasheet For the quantitative detection of human TNF-alpha in serum, plasma and cell culture supernatants. general information Catalogue Number Product Name Species cross-reactivity

More information

Contraception & HIV Still searching for answers after >2 decades

Contraception & HIV Still searching for answers after >2 decades Contraception & HIV Still searching for answers after >2 decades R Scott McClelland, MD, MPH University of Washington Inter CFAR Symposium on HIV Research in Women September 20 th 2012 Overview Global

More information

Can HPV, cervical neoplasia or. HIV transmission?

Can HPV, cervical neoplasia or. HIV transmission? Interactions between HPV and HIV: STIs and HIV shedding, regulation of HPV by HIV, and HPV VLP influence upon HIV Jennifer S. Smith Department of Epidemiology pd University of North Carolina Can HPV, cervical

More information

The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Results from the Africa Centre s population cohort

The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Results from the Africa Centre s population cohort The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Results from the Africa Centre s population cohort Frank Tanser Presentation at 8 th International Workshop on HIV Treatment,

More information

Measuring Impact PHIA Findings from Malawi, Zimbabwe, and Zambia

Measuring Impact PHIA Findings from Malawi, Zimbabwe, and Zambia Measuring Impact PHIA Findings from Malawi, Zimbabwe, and Zambia Thokozani Kalua MBBS MSc Department of HIV and AIDS, Ministry of Health, Malawi 11 th INTEREST Workshop Lilongwe, Malawi, 19 May 2017 Nothing

More information

Sexual Health reproduction in reference to treatment as/for prevention

Sexual Health reproduction in reference to treatment as/for prevention Sexual Health reproduction in reference to treatment as/for prevention The reasons for sexual reproductive health for PLHIV The number of people living with HIV (PLWH) continues to rise in the UK The increase

More information

Supplemental Figure 1. IL-3 blockade with Fab CSL362 depletes plasmacytoid dendritic cells (pdcs), but not basophils, at higher doses.

Supplemental Figure 1. IL-3 blockade with Fab CSL362 depletes plasmacytoid dendritic cells (pdcs), but not basophils, at higher doses. Supplemental Figure 1. IL-3 blockade with Fab CSL362 depletes plasmacytoid dendritic cells (pdcs), but not basophils, at higher doses. Percentage of viable (A) pdcs (Sytox Blue-, Lin1-, HLADR+, BDCA2++)

More information

University of Massachusetts Medical School Thomas A. Musich University of Massachusetts Medical School

University of Massachusetts Medical School Thomas A. Musich University of Massachusetts Medical School University of Massachusetts Medical School escholarship@umms Open Access Articles Open Access Publications by UMMS Authors 3-14-2015 HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic

More information

Tricks in HIV s bag to counter vaginal or rectal microbicides

Tricks in HIV s bag to counter vaginal or rectal microbicides Tricks in HIV s bag to counter vaginal or rectal microbicides Florian Hladik, MD, PhD University of Washington Fred Hutchinson Cancer Research Center Seattle Contribution of the various HIV invasion routes

More information

HIV fusion in Dendritic cells mainly occurs at the surface and is limited by low CD4 levels.

HIV fusion in Dendritic cells mainly occurs at the surface and is limited by low CD4 levels. JVI Accepted Manuscript Posted Online 16 August 2017 J. Virol. doi:10.1128/jvi.01248-17 Copyright 2017 American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

More information

Program to control HIV/AIDS

Program to control HIV/AIDS 90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,

More information

HIV 101: Fundamentals of HIV Infection

HIV 101: Fundamentals of HIV Infection HIV 101: Fundamentals of HIV Infection David H. Spach, MD Professor of Medicine University of Washington Seattle, Washington Learning Objectives After attending this presentation, learners will be able

More information

Hepatitis virus immunity. Mar 9, 2005 Rehermann and Nascimbeni review Crispe review

Hepatitis virus immunity. Mar 9, 2005 Rehermann and Nascimbeni review Crispe review Hepatitis virus immunity Mar 9, 2005 Rehermann and Nascimbeni review Crispe review HBV & HCV infection outcomes Both viruses cause immune-mediated active and chronic hepatitis HBV Vertical transmission

More information

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES 1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.

More information

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003 Chapter 13 Viruses, Viroids, and Prions Biology 1009 Microbiology Johnson-Summer 2003 Viruses Virology-study of viruses Characteristics: acellular obligate intracellular parasites no ribosomes or means

More information

HIV in Obstetrics and Gynecology

HIV in Obstetrics and Gynecology FAST FACTS HIV in Obstetrics and Gynecology Indispensable Guides to Clinical by J Richard Smith, Naomi Low-Beer and Bruce A Barron Practice HIV infection 7 Managing infected women 13 Preconceptual care

More information

PILOT STUDIES PROVING EFFICACY OF DENDRITIC CELL THERAPY TO PREVENT RELAPSES IN PATIENTS OF OVARIAN CA

PILOT STUDIES PROVING EFFICACY OF DENDRITIC CELL THERAPY TO PREVENT RELAPSES IN PATIENTS OF OVARIAN CA PILOT STUDIES PROVING EFFICACY OF DENDRITIC CELL THERAPY TO PREVENT RELAPSES IN PATIENTS OF OVARIAN CA DR. J. A. KHAN & DR. S. YAQIN INSTITUTE OF CELLULAR THERAPIES PVT. LTD.. BACKGROUND DEADLIEST MALIGNANCY

More information

MID 36. Cell. HIV Life Cycle. HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Entry. Life Cycle of HIV HIV Entry. Scott M. Hammer, M.D.

MID 36. Cell. HIV Life Cycle. HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Entry. Life Cycle of HIV HIV Entry. Scott M. Hammer, M.D. Life Cycle Diagnosis and Pathogenesis Scott M. Hammer, M.D. 1 Virion Entry Life Cycle of Entry 1 virion 1 Virus virion envelope Cell CD4membrane receptor RELEASE OF PROGENY VIRUS REVERSE Coreceptor TRANSCRIPTION

More information

HIV Diagnosis and Pathogenesis. HIV-1 Virion

HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Diagnosis and Pathogenesis Scott M. Hammer, M.D. HIV1 Virion Life Cycle of HIV HIV1 virion HIV1 Virus virion envelope Cell CD4membrane receptor VIRUS BINDING AND ENTRY RELEASE OF PROGENY VIRUS REVERSE

More information

HPV/Cervical Cancer Resource Guide for patients and providers

HPV/Cervical Cancer Resource Guide for patients and providers DHS: PUBLIC HEALTH DIVISION IMMUNIZATION PROGRAM HPV/Cervical Cancer Resource Guide for patients and providers Independent. Healthy. Safe. Oregon HPV Provider Resource Kit: Table of Contents Provider Information

More information

HIV behandeling, een internationaal perspectief LUT LYNEN DEPARTEMENT KLINISCHE WETENSCHAPPEN ITG

HIV behandeling, een internationaal perspectief LUT LYNEN DEPARTEMENT KLINISCHE WETENSCHAPPEN ITG HIV behandeling, een internationaal perspectief LUT LYNEN DEPARTEMENT KLINISCHE WETENSCHAPPEN ITG 1981: The beginning of AIDS The different faces of AIDS in the early days HIV prevalence world map WAAROM?

More information

Module 1: HIV epidemiology, transmission and prevention

Module 1: HIV epidemiology, transmission and prevention Session 1 Module goals Module 1 Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches

More information

HIV in Women. Why We Need Female- controlled Prevention. Heather Watts, MD March 21, 2017

HIV in Women. Why We Need Female- controlled Prevention. Heather Watts, MD March 21, 2017 HIV in Women Why We Need Female- controlled Prevention Heather Watts, MD March 21, 2017 Since the Start of PEPFAR, New HIV Infections Have Declined 51-76% 1.6 Reduction in rate of new HIV infections (incidence

More information

Welcome and State of the Network. Cape Town, South Africa 27 th September 2016

Welcome and State of the Network. Cape Town, South Africa 27 th September 2016 Welcome and State of the Network Cape Town, South Africa 27 th September 2016 The HIV/AIDS Epidemic in 2016 17 million people were accessing antiretroviral therapy 36.7 million people globally were living

More information

Microfluidic Devices for HIV Point-of-Care Diagnostics Xuanhong Cheng

Microfluidic Devices for HIV Point-of-Care Diagnostics Xuanhong Cheng Microfluidic Devices for HIV Point-of-Care Diagnostics Xuanhong Cheng Bioengineering Materials Science and Engineering Lehigh University November 30, 2018 POC Diagnostics Basic Water Supply Microdevices

More information

STARHS/RITA and Misclassification

STARHS/RITA and Misclassification Optimization and Calibration of Less Sensitive and Avidity Modified Protocols for the Vitros Immunodiagnostic Products Anti-HIV- 1+2 Assay for Detection of Early HIV Infections Sheila M. Keating, Debra

More information

AIDS at 25. Epidemiology and Clinical Management MID 37

AIDS at 25. Epidemiology and Clinical Management MID 37 AIDS at 25 Epidemiology and Clinical Management Blood HIV Transmission transfusion injection drug use Sexual Intercourse heterosexual male to male Perinatal intrapartum breast feeding Regional HIV and

More information

Progesterone Increases are Associated With HIV Susceptibility Factors in Women

Progesterone Increases are Associated With HIV Susceptibility Factors in Women Progesterone Increases are Associated With HIV Susceptibility Factors in Women Alison Y Swaims 1, Tammy Evans-Strickfaden 1, L Davis Lupo 1, Alfredo Aguirre 2, Anandi Sheth 2, Igho Ofotokun 2, Clyde E

More information

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016 New HIV Testing Algorithm from CDC ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Learning Objectives Following attendance and review of material provided, attendees will be able to: 1. Describe the new

More information

Resistance Workshop. 3rd European HIV Drug

Resistance Workshop. 3rd European HIV Drug 3rd European HIV Drug Resistance Workshop March 30-April 1 st, 2005 Christine Hughes, PharmD Clinical Associate Professor Faculty of Pharmacy & Pharmaceutical Sciences University of Alberta Tenofovir resistance

More information

2016. All Rights Reserved. 1

2016. All Rights Reserved. 1 Pamela W. Smith, M.D., MPH, MS Copyright 2016 The suggested dosages are for educational purposes only. They are suggestions for patients with normal renal and hepatic function. They are based upon my research

More information

HIV Testing. ECHO Hep C. Judith Feinberg, MD June 22, 2017

HIV Testing. ECHO Hep C. Judith Feinberg, MD June 22, 2017 HIV Testing ECHO Hep C Judith Feinberg, MD June 22, 2017 Overview A few basics HIV epidemiology in the US HIV testing Time course of HIV-1 infection symptoms HIV proviral DNA symptoms window period HIV

More information

Primary Adult Naïve CD4+ CD45RA+ Cells. Prepared by: David Randolph at University of Alabama, Birmingham

Primary Adult Naïve CD4+ CD45RA+ Cells. Prepared by: David Randolph at University of Alabama, Birmingham Primary Adult Naïve CD4+ CD45RA+ Cells Prepared by: David Randolph (drdrdr@uab.edu) at University of Alabama, Birmingham Goal: To obtain large numbers of highly pure primary CD4+ CD45RO- CD25- cells from

More information

HIV-1 Dual Infection and Neurocognitive Impairment

HIV-1 Dual Infection and Neurocognitive Impairment HIV-1 Dual Infection and Neurocognitive Impairment Gabriel Wagner, MD Assistant Professor of Medicine Infectious Diseases & Global Public Health UC San Diego HIV-Associated End Organ Damage Antiretroviral

More information

Bovine Viral Diarrhea FAQs

Bovine Viral Diarrhea FAQs Bovine Viral Diarrhea FAQs Classification BVDV is an RNA virus. It is a member of the Pestivirus genus, belonging to the family Flaviviridae 1 Two BVDV genotypes are recognized, based on the nucleotide

More information

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1 Epidemiology 227 April 24, 2009 MID-TERM EXAMINATION Select the best answer for the multiple choice questions. There are 60 questions and 9 pages on the examination. Each question will count one point.

More information

Dealing with Post-market Issues: PCV Case Study

Dealing with Post-market Issues: PCV Case Study Dealing with Post-market Issues: PCV Case Study CASE STUDY: Adventitious agent in raw material ISSUE: Presence of porcine circovirus (PCV-1) DNA detected in marketed rotavirus vaccine by an independent

More information

Table S1. Viral load and CD4 count of HIV-infected patient population

Table S1. Viral load and CD4 count of HIV-infected patient population Table S1. Viral load and CD4 count of HIV-infected patient population Subject ID Viral load (No. of copies per ml of plasma) CD4 count (No. of cells/µl of blood) 28 7, 14 29 7, 23 21 361,99 94 217 7, 11

More information

Post-Sexual Exposure Prophylaxis (npep)

Post-Sexual Exposure Prophylaxis (npep) Projeto Praça Onze Universidade Federal do Rio de Janeiro Post-Sexual Exposure Prophylaxis (npep) Mauro Schechter Principal Investigator, Projeto Praça Onze Professor of Infectious Diseases Universidade

More information

Induction of Innate Immune Responses in HVTN 071: a Trial using the MRKAd5 gag/pol/nef Vaccine from the Step Study

Induction of Innate Immune Responses in HVTN 071: a Trial using the MRKAd5 gag/pol/nef Vaccine from the Step Study Induction of Innate Immune Responses in HVTN 71: a Trial using the MRKAd5 gag/pol/nef Vaccine from the Step Study Erica Andersen-Nissen Vaccine and Infectious Disease Institute Fred Hutchinson Cancer Research

More information

HIV-1 p24 ELISA Pair Set Cat#: orb54951 (ELISA Manual)

HIV-1 p24 ELISA Pair Set Cat#: orb54951 (ELISA Manual) HIV-1 p24 ELISA Pair Set Cat#: orb54951 (ELISA Manual) BACKGROUND Human Immunodeficiency Virus ( HIV ) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to

More information

AIDS at 30 Epidemiology and Clinical Epidemiology and Management MID 37

AIDS at 30 Epidemiology and Clinical Epidemiology and Management MID 37 AIDS at 30 Epidemiology and Clinical Management Blood HIV Transmission transfusion injection drug use Sexual Intercourse heterosexual male to male Perinatal intrapartum breast feeding Adults and children

More information

With over 20 drugs and several viable regimens, the mo6vated pa6ent with life- long access to therapy can control HIV indefinitely, elimina6ng the

With over 20 drugs and several viable regimens, the mo6vated pa6ent with life- long access to therapy can control HIV indefinitely, elimina6ng the Towards an HIV Cure Steven G. Deeks, MD Professor of Medicine in Residence HIV/AIDS Division University of California, San Francisco (UCSF) WorldMedSchool; July 22, 2013 1 With over 20 drugs and several

More information

Modeling the Antigenic Evolution of Influenza Viruses from Sequences

Modeling the Antigenic Evolution of Influenza Viruses from Sequences Modeling the Antigenic Evolution of Influenza Viruses from Sequences Taijiao Jiang Center of Systems Medicine, Chinese Academy of Medical Sciences Suzhou Institute of Systems Medicine October 8-10, 2015.

More information

Unit 5: Cell Cycle, Mitosis, Meiosis & Drug Influence Influence on Nervous System

Unit 5: Cell Cycle, Mitosis, Meiosis & Drug Influence Influence on Nervous System Unit 5: Cell Cycle, Mitosis, Meiosis & Drug Influence Influence on Nervous System 1. Which of the following is NOT related to a cell s surface area to volume ratio? a. Cell size b. Number of nuclei c.

More information

Human Immunodeficiency Virus

Human Immunodeficiency Virus Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease

More information

ISBT WP-TTID Annual Report for Subgroup on Virology Drs. Michael Busch, Kurt Roth and Susan Stramer

ISBT WP-TTID Annual Report for Subgroup on Virology Drs. Michael Busch, Kurt Roth and Susan Stramer ISBT WP-TTID Annual Report for Subgroup on Virology Drs. Michael Busch, Kurt Roth and Susan Stramer Questionnaire on NAT Screening of Blood Donations for an International Forum on 10 years of NAT Screening

More information

Generation of monocytederived Dendritic Cells (modcs)

Generation of monocytederived Dendritic Cells (modcs) monocytederived Dendritic (modcs) Application Note Background Dendritic (DCs) are so called because of their characteristic cell surface projections that resemble the dendrites of neurons (see Fig 1 and

More information

Systemic monocyte activation levels and developmental milestone attainment in HIV-infected. infants initiating antiretroviral therapy.

Systemic monocyte activation levels and developmental milestone attainment in HIV-infected. infants initiating antiretroviral therapy. Systemic monocyte activation levels and developmental milestone attainment in HIV-infected infants initiating antiretroviral therapy Ira Martopullo A thesis submitted in partial fulfillment of the requirements

More information

in control group 7, , , ,

in control group 7, , , , Q1 Rotavirus is a major cause of severe gastroenteritis among young children. Each year, rotavirus causes >500,000 deaths worldwide among infants and very young children, with 90% of these deaths occurring

More information

In vivo analysis of HIV replication and persistence in the myeloid compartment

In vivo analysis of HIV replication and persistence in the myeloid compartment In vivo analysis of HIV replication and persistence in the myeloid compartment J. Honeycutt, A. Wahl, J. Foster, R.A. Spagnulo and J. Victor Garcia Division of Infections Diseases UNC Center for AIDS Research

More information

Trends in HIV Incidence and Prevalence in the United States

Trends in HIV Incidence and Prevalence in the United States Trends in HIV Incidence and Prevalence in the United States Irene Hall, PhD, FACE 7th International Workshop on HIV Transmission Washington, DC, July 20, 2012 National Center for HIV/AIDS, Viral Hepatitis,

More information

Downloaded from:

Downloaded from: O Hara, GA; Elliott, AM (2016) HIV and Helminths - Not All Worms Created Equal? Trends in parasitology. ISSN 1471-4922 DOI: https://doi.org/10.1016/j.pt.2016 Downloaded from: http://researchonline.lshtm.ac.uk/3327115/

More information

Herpes virus co-factors in HIV infection

Herpes virus co-factors in HIV infection Herpes virus co-factors in HIV infection Dr Jane Deayton Barts and the London Queen Mary School of Medicine Introduction Herpes viruses very common and often coexist with HIV Establish life-long latent

More information

Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood

Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood tree illustrating CRF01_AE gp120 protein sequence relationships between 107 Envs sampled in the RV144 trial

More information

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons

More information

Principles of Antiretroviral Therapy

Principles of Antiretroviral Therapy Principles of Antiretroviral Therapy Ten Principles of Antiretroviral Therapy Skills Building Workshop: Clinical Management of HIV Infection and Antiretroviral Therapy, 11 th ICAAP, November 21st, 2011,

More information

The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort

The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort Frank Tanser Presentation at the South African Clinicians Society Conference

More information

Anti-HIV Activity of Modified Milk Proteins and Fragments Thereof Dr. René Floris, NIZO Food Research, The Netherlands

Anti-HIV Activity of Modified Milk Proteins and Fragments Thereof Dr. René Floris, NIZO Food Research, The Netherlands Anti-HIV Activity of Modified Milk Proteins and Fragments Thereof Dr. René Floris, NIZ Food Research, The Netherlands René Floris has studied chemistry at Leiden University and obtained his PhD degree

More information

BD Flow Cytometry Reagents Multicolor Panels Designed for Optimal Resolution with the BD LSRFortessa X-20 Cell Analyzer

BD Flow Cytometry Reagents Multicolor Panels Designed for Optimal Resolution with the BD LSRFortessa X-20 Cell Analyzer Multicolor Panels Designed for Optimal Resolution with the BD LSRFortessa X-2 Cell Analyzer Proper multicolor panel design takes into account fluorochrome brightness, antigen density, co-expression, and

More information

Single and Multiple Dose Pharmacokinetics and Safety in Non-HIV-Infected Healthy Subjects Dosed with BMS , an Oral HIV Attachment Inhibitor

Single and Multiple Dose Pharmacokinetics and Safety in Non-HIV-Infected Healthy Subjects Dosed with BMS , an Oral HIV Attachment Inhibitor Single and Multiple Dose Pharmacokinetics and Safety in on-hiv-infected Healthy Subjects Dosed with 66368, an Oral HIV Attachment Inhibitor Richard ettles, Caly Chien, Erica Elefant, Xiaodong Wang, Ellen

More information